Three-dimensional (3D) real-time conformal brachytherapy - a novel solution 
for prostate cancer treatment. Part I. Rationale and method by Fijałkowski, M. et al.
Irradiation techniques • Technika napromieniania
NOWOTWORY Journal of Oncology • 2005 • volume 55
Number 1 • 58–65
Three-dimensional (3D) real-time conformal brachytherapy 
– a novel solution for prostate cancer treatment
Part I. Rationale and method
Marek Fija∏kowski1, Brygida Bia∏as1, Bogus∏aw Maciejewski2,
Joanna Bystrzycka3, Krzysztof Âlosarek3
I n t r o d u c t i o n.  Recently, the system for conformal „real-time” high-dose-rate brachytherapy has been developed and
dedicated in general for the treatment of prostate cancer. The aim of this paper is to present the 3D- conformal “real-time”
brachytherapy technique introduced to clinical practice at the Institute of Oncology in Gliwice.
M a t e r i a l  a n d  m e t h o d s.  Equipment and technique of 3D-conformal “real time” brachytherapy (3D-CBRT) is
presented in detail and compared with conventional high-dose-rate brachytherapy. Step-by-step procedures of treatment
planning are described, including own modifications.
Re s u l t s. T he 3D-CBRT offers the following advantages: (1) on-line continuous visualization of the prostate and acquisition
of the series of NS images during the entire procedure of planning and treatment; (2) high precision of definition and
contouring the target volume and the healthy organs at risk (urethra, rectum, bladder) based on 3D transrectal continuous
ultrasound images; (3) interactive on-line dose optimization with real-time corrections of the dose-volume histograms
(DVHs) till optimal dose distribution is achieved; (4) possibility to overcome internal prostate motion and set-up inaccuracies
by stable positioning of the prostate with needles fixed to the template; (5) significant shortening of overall treatment time; (6)
cost reduction – the treatment can be provided as an outpatient procedure.
C o n c l u s i o n.  The 3D- real time CBRT can be advertised as an ideal conformal boost dose technique integrated or
interdigitated with pelvic conformal external beam radiotherapy or as a monotherapy for prostate cancer.
Trójwymiarowa brachyterapia w „czasie rzeczywistym”
- nowa metoda leczenia chorych na raka gruczo∏u krokowego
Cz´Êç I. Za∏o˝enia i opis metody
W p r o w a d z e n i e.  W ciàgu ostatnich kilku lat dost´pny jest system konformalnej brachyterapii w „czasie rzeczywistym”,
z u˝yciem êróde∏ promieniowania o wysokiej mocy dawki (3D-CBRT), dedykowany dla leczenia chorych na raka gruczo∏u
krokowego. Celem opracowania jest prezentacja tej metody i techniki wdro˝onej do praktyki w Instytucie Onkologii
w Gliwicach od 2003 roku.
M a t e r i a ∏  i m e t o d y k a.  Przedstawiono i omówiono wymagane wyposa˝enie aparaturowe oraz technik´ 3D-CBRT,
w porównaniu do standardowej brachyterapii HDR. Omówiono kolejne etapy planowania i realizacji leczenia przy u˝yciu tej
metody.
W y n i k i.  Stosowanie metody 3D-CBRT wnosi nast´pujàce korzyÊci: (1) ciàg∏à trójwymiarowà wizualizacj´ „on-line”
gruczo∏u krokowego podczas wszystkich etapów planowania i realizacji leczenia; (2) wysokà precyzj´ definiowania
i konturowania obj´toÊci tarczowej i narzàdów krytycznych (cewka moczowa, odbytnica, p´cherz moczowy), w oparciu
o seri´ obrazów uzyskanych dzi´ki przezrektalnej ultrasonografii; (3) optymalizacj´ „on-line” planu leczenia i ciàg∏à korekt´
„histogramów dawki w obj´toÊci” w czasie rzeczywistym, a˝ do uzyskania optymalnego rozk∏adu dawki promieniowania; (4)
eliminacj´ ruchomoÊci gruczo∏u krokowego i niedok∏adnoÊci pozycjonowania pacjenta poprzez pe∏nà stabilizacj´ po∏o˝enia
gruczo∏u krokowego za pomocà igie∏ umocowanych w p∏ycie aplikacyjnej; (5) znaczàce skrócenie czasu leczenia; (6)
obni˝enie kosztów leczenia w wyniku mo˝liwoÊci stosowania leczenia w trybie ambulatoryjnym.
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Introduction
For over 30 years brachytherapy (BRT) has been well
established and documented method of treatment of
patients with prostate cancer. The BRT can be used as
a sole treatment modality or in combination with external
irradiation. In case of the latter it is often used as a boost
to escalate the dose to the selected subvolume or whole
target, without significant extension of overall treatment
time. An important physical and radiobiological advan-
tage of BRT is the concentration of a relatively high dose
within a well-defined target volume, and with the large
dose (dose rate) gradient within short distance out of the
target. Short treatment time allows to minimize, or even
exclude, the negative impact of the time factor on
treatment outcome.
BRT for prostate cancer with Iodine – 125 seeds was
developed in the early seventies. However, this method
was not widely popular because of unprecise dosimetry
with a relatively high local failure rate and late com-
plications. Development of transperineal techniques
under transrectal ultrasound (TRUS) guidance has led to
the widespread popularity of permanent 125I prostate
implants, and it was recognized as an effective and safe
treatment method [1]. Although the technique of
temporary removable 125I plastic tube implants solved
the problem of patient comfort, there were some dosi-
metric uncertainties and there existed a risk of cold spots
in the target volume. To meet all clinical situations and
expectations modern techniques involving computer-
controlled remote afterloading machines allowing for the
delivery of the LDR, HDR or the PDR have opened new
possibilities for brachytherapy [2-4].
Treatment planning is undertaken using a 3D-
computer system based on three-dimensional recon-
struction of the target and surrounding critical organs
from series of cross-section images of CT, MRI or US. A
variety of templates have been designed in an attempt
to render the placement of interstitial sources easier and
to obtain more homogenous dose distribution. C-arm
fluoroscopy offers step-by-step seed positioning during
and on completion of the planned implant. These
technological innovations have allowed to develop a full
therapeutic line for brachytherapy, conceptually similar to
that for external beam therapy. MSC Memorial Cancer
Center and Institute of Oncology in Gliwice has Nucle-
tron devices including LDR, HRD, PDR selectrons
connected on line with the 3D- PLATO planning system
and CT, MRI and US and C-arm fluoroscopy. Treatment
planning is connected with 3D-planning stations for
external RT through the VARIS directory.
In brachytherapy it is extremely important to
follow carefully quality assurance procedures concerning
planning and verification of treatment parameters,
applicators positioning, loading time and treatment
delivery. It is obvious that an error in brachytherapy can
be corrected, but it is more difficult to correct it than in
external-beam irradiation. However, from the first step till
the last step of treatment planning until the sources are
loaded, brachytherapy is virtual in its nature (Figure 1A).
Although there is an intension and belief that dose
distribution and delivery during treatment session(s)
reflects precisely all physical and technical parameters
planned and prescribed, optimal choice of applicators
geometry and dose distribution still remains a matter of
subjectivity.
Recently a new system (SWIFT) has been designed
and released for real-time brachytherapy for prostate
cancer. In 2002 the Institute in Gliwice was one of three
world-centers where this system has been installed and
since 2003 it is used in clinical practice. The aim of this
paper is to present the method of “real-time brachy-
therapy” (3D-CBRT).
Real-time brachytherapy
E q u i p m e n t
Real-time BRT calls for two major elements, i.e. Sure-
Point Stepping and Stabilization System and SWIFTTM v
1.0 System (Figure 2). The Sure-Point (Figure 2A) is
a device which includes an Ultrasound Transducer (US-T)
and a Needle Template (NT) fixed on the probe cradle.
The Sure-Point is designed to securely hold the US-T and
it allows for precise manual rotation and stepwise
movement of the US-T only along the longitudinal axis
and provides 3-dimmensional orthogonal positioning.
Each axis (x,y,z) can be adjusted perpendicularly and
independent of each other. After the US-T is in the
transrectal position the NT position is adjusted. To
perform calibration a needle is inserted through one of
the holes in the NT, while the US-T is on and both the NT
and the US-T are fixed on the probe cradle. A series of
transverse images 5 mm apart from the base to apex of
the prostate can be obtained. The location of the urethra
at each of these sections is measured and stored.
The SWIFTTM 0 v 1.0 (Figures 2B, C) is a moveable
unit of software applied for Real-Time – BRT planning
and consists of the real-time US images capture, real-
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W n i o s k i.  Konformalna brachyterapia w „czasie rzeczywistym” zas∏uguje na rekomendacj´ jako wysoce precyzyjna technika
podania dawki uzupe∏niajàcej (boost), zintegrowanej lub stosowanej naprzemiennie z konformalnà radioterapià, przy u˝yciu
zewn´trznych wiàzek promieniowania lub jako samodzielna metoda leczenia chorych na raka gruczo∏u krokowego.
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Figure 1. Scheme of step-by-step procedures in (A) conventional and (B) 3D-real time-conformal
brachytherapy (US – ultrasound, NOAR – normal organ at risk, DVH – dose volume histogram,
BRT – brachytherapy, QCA – quality control audit)
Figure 2. Equipment of the SWIFT System for 3D-real time conformal brachytherapy: (A) Ultra Sound
Transducer and Needle Template fixed on the probe cradle, (B/C) SWIFTTM v. 1.0 System with the real-
time US images acquisition, and US-3D treatment planning, (D) microselectron-HDR
time 3D ultrasound visualization of the prostate and of
the SWIFT treatment planning software. It is connected
on-line with Sure-Point to collect series of transversal,
transrectal US images and implant positioning.
The SWIFT-System is a “real-time” treatment plann-
ing system especially designed for the treatment of
prostate cancer. Series of direct 3D ultrasound imaging of
the implant allow to update the treatment plan during
the insertion of the catheters to the prostate. Before
treatment, the software provides anatomical and
dosimetric information, which allows to determine the
positioning and loading of radioactive sources. The
software also provides a variety of plan evolution tools to
assist in the optimization of dose distribution (e.g. dose
verification at a point and dose volume histograms).
Although SWIFT has its own database software, in
Gliwice the entire system is connected on-line via the
VARIS DIRECTORY data base with the 3D-ECLIPSE
planning system for external beam radiotherapy. In
Gliwice the VARIS is a central data base for radiotherapy.
Connection of the SWIFT with the central data base is
especially important if brachytherapy is planned as a boost
or as a part of treatment combined with external irra-
diation. Direct flow of images and brachytherapy dose-
volume histograms (DVHBr) through the VARIS to the
3D-planning stations for external irradiation increases
the precision of combined planning, especially when
conformal or IMRT techniques are used.
Re a l - t i m e  S t e p - b y - S t e p  p r o c e d u r e s
Real-time planning and delivery of brachytherapy for
prostate cancer is realized using an integrated 3D-CBRT
therapeutic line which consists of a US transrectal probe,
a stopper to fix the probe and the needle template, the
3D-treatment planning SWIFT system and HDR micro-
selectron.
Procedures (Figure 1B)
1. Positioning and imaging
The patient is placed in a dorsal lithotomy position under
spinal or general anesthesia with greatest possible pelvic
flexion. A Foley catheter is placed with a balloon
containing 7cc of contrast, and the bladder is filled with
150 cc of sterile water. A biplaner TransRectal US probe
is connected to and fixed to the template/stepper cradle to
allow only for longitudinal motion. The template has 12
columns and 12 rows of needle holes spaced at 5 mm
intervals and a large hole for the TRUS probe. The
TRUS probe is positioned and coordinated parallel to
the urethra. Both the US-T and the NT template are
displayed in the acquisition window and both must match
each other. The TRUS probe is inserted into the rectum
and moved in such a way as to place the template in
contact with the perineum. To minimize prostate motion
during imaging and implantation two stabilizing needles
are implanted into the prostate (Figure 3).
The next step is the acquisition of the transversal
US images. The stepper moves in the longitudinal
direction with the US scan density of 1-5 mm distance
between two consecutive frames to identify and to mark
the base and apex of the prostate, and urethra, rectum
and bladder. After acquiring all the necessary frames the
positions of anatomic planes (base, reference and apex)
are defined for treatment (Figure 4). The reference plane
is the largest crass-section of the prostate. The difference
in depth between the base plane and the apex plane is
called the active length. The location of the urethra is
measured and marked at each section.
2. 3D volume reconstruction and contouring
From the acquired images a 3D volume called an Image
Set is reconstructed. Each volume of interest (VOI), that
is prostate, urethra, bladder, rectum, and tumour, must
consist of at least a few contours taken from different
transversal slices. The more contours are taken – the
more precise is the 3D reconstruction. The 3D contours
are recorded, visualized and can be corrected any time
(Figure 5-A).
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Figure 3. Two stabilizing needles implanted into the prostate. The
TRUS probe is inserted into the rectum
Figure 4. Scheme of anatomic plane definitions
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3. Normalization and prescription
After defining the PTV and OAR (organ at risk) the
optimal needle position within the reference plane is
determined using a real time, interactive optimization
program. The location of each needle is measured and the
implant is automatically reconstructed, dwell weights
optimized, reference dose determined, rectal dose cal-
culated and displayed on the live US image. Dose
prescription is normalized either by the mean dose on
PTV or the minimum peripheral dose on PTV. Placement
of the needles is visualized continuously. This “live”
method allows to control needle positioning “one-by-
one” (Figure 5-B). Prescribing the number of needles the
system can warn the planner if this number is too low or
too high to achieve the prescribed dose in the selected
volumes.
4. 3D dose distribution (DVH) and optimization
(Figure 6)
For a given dose prescription the system (Figure 7-A)
visualizes the isodose distribution and the respective DVH
with corresponding dwell positions and dwell times for
the sources. If the isodose distribution and the respective
DVH do not reach the assumed and prescribed optimal
conditions the system allows for real-time corrections.
By manual or automatic corrections of isodose distri-
bution the system automatically provides the respective
corrections in DVH and in dwell times and in dwell
positions of the sources. Therefore, the geometric
anatomy related dose point optimization is performed in
real-time until the optimal level is achieved. Each step
of the optimization and its results are immediately
Figure 5A Figure 5B
Figure 5. (A) Three-dimensional visualization of the needles inserted into the prostate including position of the urethra, 
(B) Template with the all inserted needles and the TRUS probe positioned in the rectum
Figure 6. Procedure of the 3D-treatment planning – live optimalization
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displayed and the dwell weights are always given as
normalized in the range between 0 to 1.
The DVH mode allows to select the cumulative or
differential mode and it can be changed interactively.
The DVHs graphs are updated in real-time. Finally DVH
curves are displayed for all selected VOI and OAR
(Figure 7-B).
The SWIFT real-time planning is a continuous
process of step-by-step corrections displayed on each step
of correction until optimal physical and technical
parameters are achieved. After accepting the final
resolution the treatment session begins (Figure 8).
5. Dosimetric analysis
All dosimetric calculations are performed using real-time
optimization software. On each transverse TRUS image,
the 100% isodose line encompasses the contour of
prostate volume. The urethral dose is calculated on each
transverse image and is limited to ≤125% of the treatment
dose. The rectal dose is calculated at the anterior edge
within the reference plane and is limited to ≤75%. The
needle positions from TRUS are captured and optimal
DVH is generated from a dose distribution. Following
the American Brachytherapy Society (ABS) recommen-
dations, the values of D90 and D80 (dose delivered to at
least 90% and 80% of the target volume respectively)
are defined. To assess the level and range of urethral
Figure 7A Figure 7B
Figure 7. (A-upper part) 3D-reference isodose distribution (green) which does not optimally cover the whole prostate (red). Part of prostate volume
is out of the volume of the reference dose. (A-lower part) the respective virtual DVH showing non-optimal dose distribution (B-upper part) Image
(A) after 3D-real time optimalization. Reference isodose (green) covers whole prostate (red). (B-lower part) the respective “Live” optimal DVH
Figure 8. 3D-real time conformal BRT session (upper) with the
recording of dwell positions of the sources (lower)
doses the D10 (dose delivered to 10% volume of the
urethra) is recorded.
Discussion
The optimal therapy for patients with prostate cancer,
mainly for those within the moderate and high risk
groups, still remains undefined. Standard EBRT alone
or combined with standard BRT does not allow to reach
the expected therapeutic gain. A relatively large target
may not receive the prescribed dose and subvolumes of
lower doses might likely explain suboptimal results. Deve-
lopment of 3D conformal EBRT became an important
step forward to more accurate and precise covering of
the target volume while decreasing the dose to normal
tissue [5, 6]. This method allows to escalate the dose
within the tumour and recently published preliminary
studies show promising results [7, 8]. However, it is not
always easy to fully cover the target volume even in early
disease, and dose escalation may not be safe or possible,
due to geometrically unfavourable lesions. Systemic and
volume set-up errors, internal organ motion, deformation
and organ changes related to daily treatment can limit
the efficacy of the 3D – conformal EBRT [7, 9].
Computerized HDR brachytherapy (BRT) using
remote after-loading techniques is widely used in practice.
This is still useful and effective method to boost the dose
delivered by external irradiation. Stepping-source-type
HDR-BRT allows to manipulate the dose distribution by
controlling the dwell time used at each dwell position of
the sources. Optimization of treatment is the process of
determining the dwell times. This process is based on
mathematical formulas used prior to the treatment, and it
produces a number of options. Dose-point and geometric
optimization are evaluated by a physicist and a radiation
oncologist. Despite the precision and accuracy all
multistep procedures remain virtual and optimalization is
the result of subjective choices.
At the time when conformal external beam therapy
had been introduced into clinical practice, significant
progress has also been made in transrectal ultrasound
imaging of the prostate and computer – based dose
specification in brachytherapy. These technological
advances have led to the development of a new real-time
(3D-real-time CBRT), conformal, ultrasound-guided
brachytherapy dedicated for treatment of prostate cancer.
Martinez referred to this method as “the HDR-smart seed
technique” [10]. The 3D-real time CBRT presented in
this paper offers several important advantages as
compared with standard BRT and/or conformal EBRT.
First of all, it provides on-line continuous visualization
of the prostate during the whole procedure of planning
and dose delivery. Therefore, accurate definition and
contouring of the target volume and surrounding normal
organs (urethra, rectum) can be performed with high
precision. Secondly, the program allows to select and to
visualize ideal needle positions and correlate the anatomic
relationship of the organs with the needle placements
and their spatial distribution. The interactive on-line dose
optimization program allows for the visualization of
isodose curves and dose-volume histograms (DVH) in
relation to the prostate, as well as rectal and urethral
boundaries. By modification dwell positions and dwell
times in real-time the DVH can be optimized. Actual
doses at multiple prostate levels with corresponding doses
to the rectal wall and urethra are visualized and
documented during whole procedure.
Furthermore, the 3D-real time – CBRT overcomes
internal prostate motion and set-up inaccuracies found in
conformal EBRT by stable positioning of the prostate
with needles fixed by the template. There are a few other
advantages over conformal EBRT: it is much simpler and
less costly in terms of CT-based planning, simulation,
physicist and physician time, high geometric precision,
significantly shorter overall treatment time and its ability
to account and correct internal organ motion prior to
dose delivery. Martinez et al. have demonstrated no
shifting or displacement of the prostate just before and
immediately after the treatment [11].
Finally, important advantages of the 3D- real time
CBRT are (a) complete radiation protection for the
staff, (b) increased applicability because general
anesthesia and abdominal surgery are not required and
(c) significant reduction of costs, as the treatment is short
and can be performed on an outpatient basis.
Summarizing, the 3D- real time CBRT appears to be
an ideal conformal boost dose technique and when
integrated or interdigitated with pelvic conformal EBRT
it forms an effective treatment modality for patients with
prostate cancer, especially those with a large target
volume.
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